VIM and neoplasm: (F) Quantification of the percentage of EpCAM+Vim+CD24+, EpCAM+Vim+CD24- and pan-keratin+Vim+CD24+ cells in normal region (epithelium distant from the tumour), tumour body, and stromal region from metastatic and non-metastatic tumours in the first cohort of specimens.